Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 40% ± 16% | |
| endothelial cell | 3 studies | 19% ± 4% | |
| hepatocyte | 3 studies | 55% ± 16% | |
| glutamatergic neuron | 3 studies | 59% ± 13% | |
| oligodendrocyte precursor cell | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 36% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 100% | 200.23 | 359 / 359 | 97% | 8.03 | 278 / 286 |
| intestine | 100% | 260.04 | 962 / 966 | 97% | 7.41 | 513 / 527 |
| liver | 100% | 1864.86 | 226 / 226 | 97% | 16.40 | 392 / 406 |
| breast | 100% | 229.16 | 459 / 459 | 96% | 6.20 | 1070 / 1118 |
| skin | 98% | 259.43 | 1778 / 1809 | 97% | 10.96 | 456 / 472 |
| prostate | 100% | 174.05 | 244 / 245 | 93% | 4.48 | 466 / 502 |
| bladder | 100% | 219.14 | 21 / 21 | 88% | 5.73 | 446 / 504 |
| esophagus | 98% | 154.01 | 1416 / 1445 | 85% | 5.61 | 156 / 183 |
| ovary | 100% | 227.83 | 180 / 180 | 76% | 3.29 | 328 / 430 |
| lung | 92% | 120.86 | 530 / 578 | 81% | 4.17 | 934 / 1155 |
| kidney | 100% | 362.35 | 89 / 89 | 72% | 3.95 | 645 / 901 |
| uterus | 100% | 212.71 | 170 / 170 | 71% | 3.52 | 327 / 459 |
| pancreas | 100% | 220.34 | 327 / 328 | 61% | 2.33 | 109 / 178 |
| adrenal gland | 100% | 269.47 | 258 / 258 | 30% | 0.95 | 69 / 230 |
| brain | 87% | 108.55 | 2290 / 2642 | 33% | 0.99 | 232 / 705 |
| adipose | 100% | 195.97 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.01 | 1 / 1 |
| thymus | 93% | 84.44 | 609 / 653 | 5% | 0.17 | 33 / 605 |
| blood vessel | 98% | 115.35 | 1314 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 97% | 93.92 | 234 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 3.29 | 31 / 45 |
| eye | 0% | 0 | 0 / 0 | 64% | 2.31 | 51 / 80 |
| heart | 60% | 41.09 | 514 / 861 | 0% | 0 | 0 / 0 |
| muscle | 49% | 28.32 | 394 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 37% | 60.68 | 346 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.74 | 6 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0005997 | Biological process | xylulose metabolic process |
| GO_0046835 | Biological process | carbohydrate phosphorylation |
| GO_0016310 | Biological process | phosphorylation |
| GO_0006091 | Biological process | generation of precursor metabolites and energy |
| GO_0019640 | Biological process | glucuronate catabolic process to xylulose 5-phosphate |
| GO_0005998 | Biological process | xylulose catabolic process |
| GO_0042732 | Biological process | D-xylose metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0004856 | Molecular function | D-xylulokinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | XYLB |
| Protein name | Xylulose kinase (Xylulokinase) (EC 2.7.1.17) Xylulokinase XYLB protein Xylulose kinase (EC 2.7.1.17) |
| Synonyms | FLJ12539 FLJ22075 FLJ10343 |
| Description | FUNCTION: Phosphorylates D-xylulose to produce D-xylulose 5-phosphate, a molecule that may play an important role in the regulation of glucose metabolism and lipogenesis. . FUNCTION: Phosphorylates D-xylulose to produce D-xylulose 5-phosphate, a molecule that may play an important role in the regulation of glucose metabolism and lipogenesis. . |
| Accessions | ENST00000650590.1 O75191 ENST00000427323.5 A0A3B3IRM4 A0A3B3IS07 C9J0N9 Q6PIS3 ENST00000207870.8 [O75191-1] F8WBF6 ENST00000649234.1 ENST00000424034.5 |
